| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $147.1M | +112.6% |
| Cost of Revenue | $144.2M | +115.9% |
| Gross Profit | $2.9M | +20.5% |
| R&D Expense | $8.1M | -12.0% |
| SG&A Expense | $12.1M | -2.6% |
| Operating Income | -$55.2M | +10.6% |
| Pre-tax Income | -$53.9M | +10.8% |
| Income Tax | $1K | +0.0% |
| Net Income | -$53.9M |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.5M | -44.4% |
| Accounts Receivable | $1.7M | -63.4% |
| Inventory | $2.7M | -77.2% |
| Current Assets | $39.8M | -43.1% |
| Total Assets | $41.8M | -42.5% |
| Current Liabilities | $47.1M | -1.1% |
| Total Liabilities | $47.9M | -2.4% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.6M | +16.9% |
| Capital Expenditures | $71K | — |
| Investing Cash Flow | -$71K | — |
| Financing Cash Flow | $16.4M | -67.7% |
| Free Cash Flow | -$34.7M | — |
| +10.8% |
| EPS (Basic) | -$0.21 | +16.0% |
| EPS (Diluted) | -$0.21 | +16.0% |
| Stockholders' Equity |
| -$6.0M |
| -125.5% |